U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease
Biden administration asserts power to seize drug patents in move to slash high prices
U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients
Biden administration delays ban on menthol cigarettes until 2024
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
Senators launch bipartisan probe of private equity's growing role in U.S. health care
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
CVS to change how it prices prescription drugs with new pharmacy reimbursement model
